At present, there is no drug that can make Hepatitis B minor III completely turn negative, but clinically, anti-hepatitis B virus drugs (such as entecavir, etc.) can be used to inhibit the replication of the virus and achieve clinical cure.
Hepatitis B antiviral drugs mainly include interferon, nucleoside analogs (e.g., entecavir, tenofovir, etc.), etc. Usually, the duration of antiviral treatment is relatively long, at least 1 year or more, and during the period of treatment, it is necessary to regularly review the hepatitis B pentameter, hepatitis B viral DNA load, liver function, and liver imaging, etc., and to evaluate the timing of discontinuation of the drug in the light of the patient’s own situation, as well as to monitor the side effects of the drug.
In addition, even with regular viral therapy, the possibility of complete conversion of hepatitis B is small. In general, the purpose of hepatitis B treatment is to try to inhibit viral replication and control it to undetectable range, and at the same time, to avoid prolonged disease, liver fibrosis, cirrhosis and even liver cancer, etc., rather than to completely convert to the negative as the main purpose, and at present there is no medication for curing hepatitis B minor triple yang.
Patients should go to the hospital regularly for follow-up, under the guidance of the doctor, complete the relevant examinations, clarify the condition and give systematic and regular treatment. The choice and use of drugs should be under the guidance of a doctor, not self-medication.